Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04729803 · ClinicalTrials.gov registry record · NA
Attention, Teleconferencing and Social Anxiety
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04729803: Completed NA study, sponsored by University of Texas at Austin.
NCT04729803 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04729803, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This study involves completing some online assessments and an intervention for social anxiety that all involve interactions with other people on a teleconferencing call.
Primary Outcome
Assessment of communication concerns, range of scores is 24-120; higher scores are worse
Interventions
- BEHAVIORAL Experimental: Attention Guidance + Exposure
- BEHAVIORAL Active Comparator: Exposure Alone
- BEHAVIORAL Experimental: Attention Control + Exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-01-18 |
| Est. Completion | 2022-06-30 |
| Phase | NA |
What the finished NCT04729803 record still lists
NCT04729803 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Experimental: Attention Guidance + Exposure is the first listed.
NCT04729803 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04729803 about?
NCT04729803 is a clinical study titled "Attention, Teleconferencing and Social Anxiety". This study involves completing some online assessments and an intervention for social anxiety that all involve interactions with other people on a teleconferencing call.
What is the current status of trial NCT04729803?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-01-18. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT04729803?
The interventions under investigation include: Experimental: Attention Guidance + Exposure (BEHAVIORAL), Active Comparator: Exposure Alone (BEHAVIORAL), Experimental: Attention Control + Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04729803?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04729803's enrollment target sits among peer trials
53 1271st of 2000 higher than 729 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI